Please assess the completion status of the following clinical trial:

Trial Title: Time Course Adaptations Using Deuterated Creatine (D3Cr) Method

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* men and women aged 70 or greater~* at high risk for mobility disability based on lower extremity functional limitations measured by Short Physical Performance battery (SPPB) with a score ≤ 8 out of 12~* could safely participate in the resistance training intervention as determined by medical history and physical examination.~* willing to give informed consent to be randomized to either the resistance training group or successful aging heath education comparison group and willing to follow the study protocol~Exclusion Criteria:~* Severe cardiac disease, including NYHA Class III or IV congestive heart failure, clinically significant aortic stenosis, history of cardiac arrest, use of a cardiac defibrillator, or uncontrolled angina~* Myocardial infarction, major heart surgery, stroke, deep vein thrombosis, or pulmonary embolus in the past 6 months~* Lung disease requiring either oral or injected steroids, or the use of supplemental oxygen~* Short, portable mental status questionnaire with 3 or more errors~* Severe arthritis (either osteoarthritis or rheumatoid arthritis) that severely limits mobility~* Severe lower back or shoulder pain that can worsen with weight lifting exercises.~* Cancer requiring treatment in the past 1 year (Melanomas excluded)~* Any present or recent history of severe psychiatric illness including depression that might preclude providing informed consent, safe participation, or compliance (self-report and investigator judgement~* Development of chest pain or severe shortness of breath on the 400 m self-paced walk test~* Parkinson's disease or other serious neurological disorders; renal disease requiring dialysis; other illness of such severity that life expectancy is considered to be less than 12 months~* Current diagnosis of schizophrenia, other psychotic disorders, or bipolar disorder~* Current consumption of more than 14 alcoholic drinks per week~* Uncontrolled hypertension (systolic blood pressure \> 200 mm Hg and/or diastolic blood pressure \>110 mm Hg)~* Currently on testosterone, Dehydroepiandrosterone (DHEA), or anabolic steroids.~* Undergoing physical therapy involving the lower extremities~* Currently enrolled in another randomized trial involving a pharmaceutical or lifestyle intervention. Observational studies are permitted~* Participation in progressive resistance exercise regimen ( ≥1 day/week) within the previous 6 months prior to screening.~* Weight change (intentional or not) over the last 6 months of \> 5% of body or plan to lose or gain weight during the study~* Any other cardiovascular, pulmonary, orthopedic, neurologic, or other conditions that in the opinion of the local clinician would preclude participation and successful completion of the protocol~Temporary Exclusion Criteria:~* Recent bacterial/viral infection (e.g. pneumonia) (\< 2 weeks);~* Acute febrile illness in past 2 months;~* Severe hypertension, e.g., SBP \> 200 mm Hg, DBP \> 110 mm Hg~* Major surgery or fracture or hip/knee replacement (\< 6 months);~* Hospitalization within the last 6 months ( Not ER visits)

- Gender: ALL
- Minimum Age: 70 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Resistance Training group (RT) (Type: EXPERIMENTAL): The resistance training intervention will include a full body, resistance training performed three days per week.The intensity, volume, tempo, and progression will be based on the Federal Physical Activity guidelines
- Successful Aging (Type: ACTIVE_COMPARATOR): The comparator group will meet for stretching and health education classes every 2-5 weeks up to 7 total visits.

Based on this trial design, predict the completion outcome and termination type (if applicable).